SAB Biotherapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in SAB Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including SAB Biotherapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SAB Biotherapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $654 | 951 | 0.69 |
| 2023-09-30 | $584 | 927 | 0.63 |
| 2023-06-30 | $730 | 881 | 0.83 |
| 2023-03-31 | $0 | 881 | 0.00 |
| 2022-12-31 | $1.0k | 881 | 1.14 |
| 2022-06-30 | $3.0k | 1.8k | 1.66 |
| 2022-03-31 | $19k | 5.0k | 3.80 |
| 2021-12-31 | $30k | 3.8k | 7.83 |